Autoimmunity by anti-tumour necrosis factor-alpha agents: The role of traditional therapies

Journal of the European Academy of Dermatology and Venereology

Volumn 24, Issue 3, 2010, Pages 356-357

  Antoniou, C ^a   Moustou, A E ^a   Vergou, T ^a   Stratigos, A ^a   Kalambokas, A ^a   Katsambas, Ad ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CYCLOSPORIN A; DOUBLE STRANDED DNA ANTIBODY; DRUG ANTIBODY; EFALIZUMAB; ETANERCEPT; INFLIXIMAB; METHOTREXATE; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; DERMATOLOGICAL AGENT; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ACUTE PERICARDITIS; ADD ON THERAPY; ADULT; ANKLE; ANTIBODY TITER; ARTHRALGIA; AUTOIMMUNITY; CASE REPORT; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; DRUG INFUSION; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FACE ERYTHEMA; FEVER; FLUSHING; HUMAN; INFLAMMATION; LETTER; LUPUS LIKE SYNDROME; MALE; MYOCARDITIS; PERICARDITIS; PHOTOSENSITIVITY; PRIORITY JOURNAL; PRURITUS; PSORIASIS; PSORIATIC ARTHRITIS; RECURRENT DISEASE; RELAPSE; SCORING SYSTEM; THORAX PAIN; TREATMENT RESPONSE; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; FOLLOW UP; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION;

ADULT; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; AUTOIMMUNITY; DERMATOLOGIC AGENTS; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; PSORIASIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 76349084074     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03386.x     Document Type: Letter

References (9)

1. Tutrone WD, Saini R, Weinberg JM. Biological therapy for psoriasis: an overview of infliximab, etanercept, efalizumab and alefacept. IDrugs 2004 7 : 45 49. (Pubitemid 44296421)
2. Isaacs JD. The antiglobulin response to therapeutic antibodies. Semin Immunol 1990 2 : 449 456.
3. Cheifetz A, Mayer L. Monoclonal antibodies, immunogenicity, and associated infusion reactions. Mt Sinai J Med 2005 72 : 250 256.
4. De Rycke L, Baeten D, Kruithof E, Van den Bosch F, Veys EM, De Keyser F. Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis. Arthritis Rheum 2005 52 : 2192 2201.
5. Atzeni F, Turiel M, Capsoni F, Doria A, Meroni P, Sarzi-Puttini P. Autoimmunity and anti-TNF-α agents. Ann N Y Acad Sci 2005 1051 : 559 569.
6. Eriksson C, Engstrand S, Sundqvist KG, Rantapää-Dahlqvist S. Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF α. Ann Rheum Dis 2005 64 : 403 407.
7. De Bandt M, Sibilia J, Le Loët X et al. Systemic lupus erythematosus induced by anti-tumor necrosis factor alpha therapy: a French national survey. Arthritis Res Ther 2005 7 : R545 R551.
8. Egner W. The use of laboratory tests in the diagnosis of SLE. J Clin Pathol 2000 53 : 424 432.
9. Ramos-Casals M, Brito-Zerón P, Muñoz S et al. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore) 2007 86 : 242 251.